UNION CITY, Calif., April 24, 2014 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, today reported financial results for the fourth quarter and fiscal year ended March 31, 2014.
Fourth quarter and fiscal 2014 results include:
-- Medical reagent disc sales of 740,000 units for the fourth quarter, up 37% over last year’s comparable quarter, and 2.7 million units for fiscal 2014, up 10% year-over-year.
Help employers find you! Check out all the jobs and post your resume.
